Skip to main content
CSE:SENS

Senseonics Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive SENS News and Ratings via Email

Sign-up to receive the latest news and ratings for Senseonics and its competitors with MarketBeat's FREE daily newsletter.


About Senseonics

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to 90 and 180 days. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company was founded in 1996 and is headquartered in Germantown, Maryland.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone301 515 7260
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$4.95 million
Book Value-0.54 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings DateN/A
OptionableOptionable

MarketRank

Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Senseonics (CSE:SENS) Frequently Asked Questions

What stocks does MarketBeat like better than Senseonics?

Wall Street analysts have given Senseonics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Senseonics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Senseonics' next earnings date?

Senseonics is scheduled to release its next quarterly earnings announcement on Thursday, May 13th 2021.
View our earnings forecast for Senseonics
.

Who are Senseonics' key executives?

Senseonics' management team includes the following people:
  • Dr. Timothy T. Goodnow, Pres, CEO & Director (Age 59, Pay $1M)
  • Dr. Mukul Jain, Chief Operating Officer (Age 48, Pay $595.17k)
  • Dr. Francine Ratner Kaufman, Chief Medical Officer & Director (Age 69, Pay $590.06k)
  • Mr. Nick B. Tressler M.B.A., CFO, Sec. & Treasurer (Age 48)

Who are some of Senseonics' key competitors?

What is Senseonics' stock symbol?

Senseonics trades on the Canadian Securities Exchange (CSE) under the ticker symbol "SENS."

How do I buy shares of Senseonics?

Shares of SENS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

How much money does Senseonics make?

Senseonics has a market capitalization of $0.00 and generates $4.95 million in revenue each year.

How many employees does Senseonics have?

Senseonics employs 82 workers across the globe.

What is Senseonics' official website?

The official website for Senseonics is www.senseonics.com.

How can I contact Senseonics?

The company can be reached via phone at 301 515 7260.


This page was last updated on 5/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.